Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Hunter

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Medical Care|October 1, 1985
Formal relationships among governing boards, CEOs, and medical staffs in independent and system hospitalsL L Morlock, J A Alexander, H M Hunter
Leukemia|October 27, 2006
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412C H Seedhouse, H M Hunter, B Lloyd-Lewis, et al.
British Journal of Haematology|February 3, 2005
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiationH M Hunter, K Peggs, R Powles, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Medical Care|October 1, 1985
Formal relationships among governing boards, CEOs, and medical staffs in independent and system hospitalsL L Morlock, J A Alexander, H M Hunter
Leukemia|October 27, 2006
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412C H Seedhouse, H M Hunter, B Lloyd-Lewis, et al.
British Journal of Haematology|February 3, 2005
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiationH M Hunter, K Peggs, R Powles, et al.
Pageof 1